News articles for Decision Resources:
Tuesday, May 21, 2013
Monday, May 20, 2013
Tuesday, May 14, 2013
Monday, May 13, 2013
Thursday, May 9, 2013
Wednesday, May 8, 2013
Tuesday, May 7, 2013
Tuesday, April 30, 2013
Monday, April 29, 2013
Wednesday, April 24, 2013
Tuesday, April 23, 2013
Tuesday, April 16, 2013
Tuesday, April 9, 2013
For Postherpetic Neuralgia, Current and Emerging Therapies Have No Significant Advantage Over Pfizer's Lyrica on the Attribute of Reducing Pain Intensity
BURLINGTON, Mass., April 9, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that reduction in pain intensity is one of the attributes that most influences their decisions ...
read moreMonday, April 8, 2013
Thursday, April 4, 2013
Wednesday, April 3, 2013
Tuesday, April 2, 2013
Wednesday, March 27, 2013